Robotic automation systems for histology and pathology laboratories
Clarapath builds electro-mechanical robots that automate tissue sectioning in histology labs, with SectionStar and TrimStar Pro as its device lines. The stack pairs embedded tooling (C++, ROS, FPGA, I2C, Modbus, RS-485) with optics software like Zemax, and RTOS adoption points to tighter real-time device control. Hiring is accelerating and engineering-heavy, with manufacturing and field support roles signaling a shift from R&D toward deployment.
Clarapath is a privately held medical robotics company headquartered in Hawthorne, New York, with 51–200 employees. It develops automated systems for histology laboratories, including SectionStar, which prepares tissue samples for pathologists to use in diagnosis. Its products aim to lower lab costs and make laboratory processes more consistent. The company sells to clinical laboratories and pathology groups. Its teams cover engineering, manufacturing, field support, operations and sales, and it hires in the United States.
Clarapath uses C++, Python, ROS, FPGA, MATLAB and Zemax for device and optics work. It relies on serial protocols such as I2C, Modbus and RS-485, and on AWS, Docker, Kubernetes, React and PostgreSQL for software. It is adopting RTOS.
Clarapath is building control software, computer vision and electrical systems for its SectionStar and TrimStar Pro devices. It is also running beta testing, validation and field deployments of product updates.
Clarapath is headquartered in Hawthorne, New York, in Westchester County. It has 51–200 employees and hires in the United States.
Other companies in the same industry, closest in size
Clarapath's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.